KPA requested Pfizer to explain tablet blended mishaps.

The KPA criticized Pfizer over the administrative warning penalty charged to the pharmacist who first found the mishap Cofrel and Cardura tablets intermixed in the same bottle and decided to blame Pfizer through the public hearing over their neglecting the basic responsibility that the drug suppliers should bear. For this task, the KPA nominated Mr. Chung Myung-jin as the chief commissioner of...